Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent
Providing, when possible, the identification of all drugs present in the specimen
This test is not intended for use in employment-related testing.
This test is not intended for therapeutic compliance testing.
This test is not useful for drugs of abuse or illicit drug testing, including benzodiazepines, opioids, barbiturates, cocaine, and amphetamine type stimulants.
Gas Chromatography-Mass Spectrometry (GC-MS)
acetaminophen
amitriptyline
amobarbital
bupropion
butabarbital
butalbital
caffeine
carbamazepine
carisoprodol
chlorpheniramine
chlorpromazine
citalopram
clomipramine
clozapine
codeine
cyclobenzaprine
dextromethorphan
diazepam
diphenhydramine
doxepin
doxylamine
fentanyl
fluoxetine
guaifenesin
ibuprofen
imipramine
lamotrigine
levetiracetum
lidocaine
meperidine
mephobarbital
meprobamate
metaxalone
methadone
methsuximide
methylphenidate
midazolam
mirtazepine
naproxen
nordiazepam
nortriptyline
oxcarbazepine metabolite
pentobarbital
phenobarbital
primidone
promethazine
propofol
secobarbital
sertraline
strychnine
theophylline
thioridazine
topiramate
tramadol
trazodone
trimipramine
venlafaxine
zaleplon
zolpidem
Urine
For chain-of-custody testing, order PDSUX / Drug Screen, Prescription/Over the Counter, Chain of Custody, Random, Urine. For situations where chain of custody is required, a Chain-of-Custody Kit (T282) is available.
Supplies: Sarstedt 5 mL Aliquot Tube (T914)
Collection Container/Tube: Plastic urine container
Submission Container/Tube: Plastic vial
Specimen Volume: 5 mL
Collection Instructions:
1. Collect a random urine specimen.
2. No preservative.
Additional Information: See Prescription and Over-the-Counter (OTC) Drug Screens in Special Instructions.
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.
1.1 mL
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Refrigerated (preferred) | 14 days | |
Frozen | 14 days | ||
Ambient | 3 hours |
Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent
Providing, when possible, the identification of all drugs present in the specimen
This test is not intended for use in employment-related testing.
This test is not intended for therapeutic compliance testing.
This test is not useful for drugs of abuse or illicit drug testing, including benzodiazepines, opioids, barbiturates, cocaine, and amphetamine type stimulants.
This test looks for a broad spectrum of prescription and over-the-counter (OTC) drugs. It is designed to detect drugs that have toxic effects, as well as known antidotes or active therapies that a clinician can initiate to treat the toxic effect. The test is intended to help physicians manage an apparent overdose or intoxicated patient, or to determine if a specific set of symptoms might be due to the presence of drugs. This test is not appropriate for drugs of abuse or illicit drug testing, including benzodiazepines, opioids, barbiturates, cocaine, and amphetamine type stimulants.
Drugs of toxic significance that are not detected by this test are: digoxin, lithium, salicylate and many drugs of abuse or illicit drugs, some benzodiazepines, and some opioids. For these drugs, see Mayo Clinic Laboratories' drug abuse surveys, drug screens, or individual tests.
See Prescription and Over-the-Counter (OTC) Drug Screens in Special Instructions for detection limits for drugs detected in this test.
Drugs detected are presumptive. Additional testing may be required to confirm the presence of any drugs detected.
The drugs that can be detected by this test are listed in Prescription and Over-the-Counter (OTC) Drug Screens in Special Instructions.
A detailed discussion of each drug detected is beyond the scope of this text. Each report will indicate the drugs identified. If a clinical interpretation is required, request a Clinical and Forensic Toxicology Lab consult (Mayo Clinic patients) or contact Mayo Laboratory Inquiry (Mayo Clinic Laboratories clients).
No significant cautionary statements.
1. Langman LJ, Bechtel LK, Meier BM, Holstege C: Clinical toxicology. In: Rifai N, Horvath AR, Wittwer CT, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 6th ed. Elsevier; 2018:1294
2. Baselty RC: Disposition of Toxic Drugs and Chemicals in Man. 10th ed. Biomedical Publications, 2014
Monday through Friday
This test was developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.
80307
Test Id | Test Order Name | Order LOINC Value |
---|---|---|
PDSU | Drug Screen, Prescription/OTC, U | 12286-1 |
Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
31260 | Drugs detected: | 12286-1 |
45529 | Suspect Drug | No LOINC Needed |
31262 | Chain of Custody | 77202-0 |